Drug Search Results
More Filters [+]

Sulprostone

Alternative Names: sulprostone
Latest Update: 2024-05-03
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: EP2 Analogue

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Austria | France | Greece | Hungary | India | Italy | Korea | Netherlands | Pakistan | Portugal | Switzerland | Taiwan | Thailand

Approved Indications: None

Known Adverse Events: None

Company: Atrium Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sulprostone

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events